share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director FREYMAN THOMAS C

SEC announcement ·  May 8 06:36
Summary by Futu AI
Thomas C. Freyman, associated with AbbVie Inc. [ABBV], completed a transaction on May 3, 2024, acquiring 1,322 shares of common stock at no cost. Following this transaction, Freyman's direct holdings in AbbVie amount to 125,548 shares. Additionally, indirect holdings through family trusts total 7,882 shares, with 4,000 held by a spouse in trust and 3,882 held by a spouse as trustee for their son. The transaction has been marked as completed.
Thomas C. Freyman, associated with AbbVie Inc. [ABBV], completed a transaction on May 3, 2024, acquiring 1,322 shares of common stock at no cost. Following this transaction, Freyman's direct holdings in AbbVie amount to 125,548 shares. Additionally, indirect holdings through family trusts total 7,882 shares, with 4,000 held by a spouse in trust and 3,882 held by a spouse as trustee for their son. The transaction has been marked as completed.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.